Search results for: Competition
Filter search results
Pricing Variations Within and Across Countries: Gauging Efficiency
25 February 2014
…and across the full range of incomes. The authors examine the effects of per capita income, income dispersion, competition from originator and generic substitutes, and whether the medicine is available…
OHE is Pleased to Announce the Appointment of Two New Economists: Margherita Neri and Jimena Ferraro
14 February 2017
…of health care as well as aspects of competition in healthcare and pharmaceutical markets. As part of her MSc dissertation, she led an empirical study on the effect of a…
Financing and Scaling Innovation for the COVID Fight: A Closer Look at Demand-Side Incentives for a Vaccine
1 April 2020
…three options: business as usual – which may lead to promotion of an inferior vaccine or fierce country competition for supply – and two models (cost- or value-based), with countries…
Virtual OHE Annual Lecture 2021: Do Patents Work? Evidence from Pharmaceutical Innovation
14 October 2021, 1:00pm
…to patents, such as prizes and government grants. Margaret Kyle is a recognised expert on competition and intellectual property in the pharmaceutical industry. She has researched the role of geographic…
Health Care Services and the Single European Market
1 September 2008
…health systems are compatible; the potential impact of increased competition on efficiency, quality and access to health services and the effect of relying on patient choice to promote competition; and…
Managed Care – An Option for the German Health Care System?
1 April 1998
…– is a prominent part of most other western European social systems too. However, service provision and insurance could be so co-ordinated under the banner of ‘managed competition’ that the…
Economics of Innovative Payment Models Compared with Single Pricing of Pharmaceuticals
1 July 2018
…are sometimes neglected: optimising incentives for R&D means indications that can provide cost-effective treatment are likely to be developed, and there is the potential for increased price competition at the…
Combination Therapies: A Step Forward to the Value Attribution Problem
4 January 2023
…VP of Global Value and Access at Amgen, discussed the four policy domains that need to be addressed to improve access to CTs: the incentive problem, the implementation problem, competition…
The Impact of Biosimilars on Markets
24 May 2010
…has enacted the Biologics Price Competition and Innovation Act of 2009 (a subtitle of the Patient Protection and Affordable Health Care Act signed into law in March 2010). Among other things,…